Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.

Albhaisi S, Tondt J, Cyrus J, Chinchilli VM, Conroy DE, Stine JG

Open source

DOI
10.1097/hc9.0000000000000499
Published
2024 Aug 1
Container
Hepatology communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/hc9.0000000000000499,
  title = {Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.},
  author = {Albhaisi S and Tondt J and Cyrus J and Chinchilli VM and Conroy DE and Stine JG},
  year = {2024},
  journal = {Hepatology communications},
  doi = {10.1097/hc9.0000000000000499},
  url = {https://doi.org/10.1097/hc9.0000000000000499}
}

RIS

TY  - JOUR
TI  - Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.
AU  - Albhaisi S
AU  - Tondt J
AU  - Cyrus J
AU  - Chinchilli VM
AU  - Conroy DE
AU  - Stine JG
PY  - 2024
JO  - Hepatology communications
DO  - 10.1097/hc9.0000000000000499
UR  - https://doi.org/10.1097/hc9.0000000000000499
ER  - 

APA

S, A., J, T., J, C., VM, C., DE, C., & JG, S. (2024). Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.. Hepatology communications. https://doi.org/10.1097/hc9.0000000000000499

Source records